CAH Cardinal Healthdata gap · 19% coveragelimited data
Health Care · Health Care Distributors · close $254.06 (2026-10-16) · latest quarter in EDGAR:
Cardinal Health (CAH) has a ThetaGrade House Rating of 49/100 (grade D), ranking #28 of 150 in Health Care. Its strongest pillars are cash flow (94) and analyst sentiment (83); its weakest is balance sheet (6). Data gap: 10 factors without usable data, so 19% of the method weight is covered. TTM revenue growth is — and operating margin —.
Data as of .
Data gap
No usable data for: Revenue growth YoY (TTM), EPS growth YoY (TTM), Revenue acceleration, Operating margin, 4Q gross-margin change, Net debt / EBITDA, Interest coverage, FCF margin, P/E (inverted), EV/Sales (inverted). Data gap: no usable data for this factor, so it is left out and its weight is shared among the factors that do have data (no value is imputed). 19% of the full method weight is backed by data.
- Revenue: no revenue tag with current data (latest tagged quarter 2025-12-31) - data gap
Analyst sentiment
weight 7.5% (→19.6%) · 83| Consensus score (1–5) (9.8%) | derived | 94 |
| 90-day net rating shift (9.8%) | derived | 70 |
Growth
weight 30.83% · no data · —| Revenue growth YoY (TTM) (0.0%)data gap | — | — |
| EPS growth YoY (TTM) (0.0%)data gap | — | — |
| Revenue acceleration (0.0%)data gap | — | — |
Profitability
weight 18.5% · no data · —| Operating margin (0.0%)data gap | — | — |
| 4Q gross-margin change (0.0%)data gap | — | — |
Balance sheet
weight 18.5% (→48.3%) · 6| Net debt / EBITDA (0.0%)data gap | — | — |
| Current ratio (48.3%) | 0.88 | 6 |
| Interest coverage (0.0%)data gap | — | — |
Cash flow
weight 12.33% (→32.2%) · 94| FCF margin (0.0%)data gap | — | — |
| FCF yield (32.2%) | 7.7% | 94 |
Valuation
weight 12.33% · no data · —| P/E (inverted) (0.0%)data gap | — | — |
| EV/Sales (inverted) (0.0%)data gap | — | — |
Technicals (EOD)
| RSI(14) | 74.1 |
| EMA 9 / 21 | 243.34 / 237.21 |
| 200-day SMA | 219.87 |
| Volume vs 20d avg | 0.72× |
| 20-day return | 12.2% |
Exit-rule monitor
- EXITRating break: House Rating below 60
Data source per metric (SEC XBRL tag or derivation): Interest expense: InterestExpense · D&A: DepreciationDepletionAndAmortization · Market cap: SEC shares (dei EntityCommonStockSharesOutstanding (cover page)) × EOD close.
Get rating changes like CAH's in the free Daily Brief
The market’s key events and signals, digested before the open.
- ✓ Pre-market Daily Brief: events, headlines, rating changes (2-min read)
- ✓ Sunday: Top 5 Weekly Picks, exit alerts, CSP put watchlist
- ✓ OPEX, FOMC, CPI and jobs-day reminders
Free. Want more? See Premium (waitlist).
FAQ
- What is CAH's House Rating?
- CAH scores 49 out of 100 (grade D) as of 2026-10-16, ranking #28 of 150 Health Care stocks we cover.
- What do analysts say about CAH?
- ThetaGrade's analyst-sentiment pillar for CAH scores 83/100 against its sector peers, which we read as positive. This is our own derived score; we do not republish individual analyst ratings, counts or targets.
- When does CAH report earnings next?
- CAH's next earnings report is estimated for about 2026-10-29 (window 2026-10-22 to 2026-11-05), based on its past SEC 8-K earnings filings. This is an estimate, not a company-confirmed date.
- Is CAH a buy?
- ThetaGrade does not give personal advice. The House Rating is an educational, rules-based summary of public data; see the methodology for how it is built.
Sources: SEC EDGAR filings (fetched 2026-10-18), Finnhub recommendation trends, Massive EOD prices. Scores are sector percentiles; a factor without usable data is a data gap: it is left out and the remaining weights are renormalized (nothing is imputed). Educational only. Methodology